CrossrefInfokarte
The importance of central sensitization for clinical trials of disease modifying osteoarthritis drugs (DMOADs)
Osteoarthritis Imaging · 2025-03 · 5 (1) · 100261
DOI: 10.1016/j.ostima.2025.100261 ↗Abstract
Kein Abstract verfügbar.
EUVIMED